Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 433, 790 (24 February 2005) | doi:10.1038/433790b; Published online 23 February 2005
Open Innovation Challenges
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
- More Challenges
- Powered by:
nature jobs
Business Devlopment Officer
- Rhydburg Pharmaceuticals
- Selaqui-Dehradun India
Full-Professor of Heart and Thoracic Surgery (W3) (f / m)
- Friedrich-Schiller-University Jena
- Jena Germany
Vioxx may go back on sale after scraping past FDA panel
Meredith Wadman
Advisers to the US Food and Drug Administration (FDA) have voted, by a narrow margin, that it should not ban Vioxx — the painkiller withdrawn by drug-maker Merck.They also said that Pfizer's Celebrex and Bextra, two other members of the family of painkillers known as COX-2 inhibitors, should remain available, despite the fact that they too boost patients' risk of heart attack and stroke.
To read this story in full you will need to login or make a payment (see right).
